Skip to content

LEDGER2026 YTD $21.4B253 roundslast Oct 20, 2026

Series A

Scala Biodesign raises $16M Series A

$16M

By Israel Rounds desk. Edited by Eliran Yihye. Published . Updated .

Scala Biodesign raised $16M in a Series A round1, announced Mar 31, 20261, led by Grove Ventures1.

Also participating: TLV Partners, Deep Insight and Israel Innovation Authority1.

Lead investor

  • Grove Ventures

Also participating

  • TLV Partners
  • Deep Insight
  • Israel Innovation Authority

Sources

  1. 1CTech, Mar 31, 2026. “Scala Biodesign raises $16 million Series A to accelerate AI-driven drug development”

How much did Scala Biodesign raise in its Series A?

Scala Biodesign raised $16M in its Series A, announced Mar 31, 2026.

Who led Scala Biodesign’s Series A?

The round was led by Grove Ventures.

Which investors took part in Scala Biodesign’s Series A?

Participants: Grove Ventures, TLV Partners, Deep Insight and Israel Innovation Authority.

How much has Scala Biodesign raised in total?

Scala Biodesign has raised $16M across 1 recorded round.